Compare Bank of Nova Scotia (BNS) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Nova Scotia vs Heron Therapeutics Inc — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Bank of Nova Scotia is far larger — about 1762.2× Heron Therapeutics Inc's market cap, and Bank of Nova Scotia pays a 3.64% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BNS | HRTX | |
|---|---|---|
Market Cap | $108.32B | $61.47M |
Sector | Financials | Health |
52-Week High | $90.29 | $1.49 |
52-Week Low | $56.41 | $0.32 |
Dividend Yield | 3.64% | — |
Enterprise Value | — | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
